External compression of left main bronchus by a large patent ductus arteriosus: a case report

Abstract In neonates and infants, the trachea and main bronchus may be compressed by adjacent cardiovascular structures. Compression of the main bronchi by the patent ductus arteriosus is rare and causes a variety of respiratory problems. Surgical closure of the patent ductus arteriosus that compresses the main bronchus as soon as possible is an effective treatment option. Rapid clinical recovery is expected after surgical closure of the patent ductus arteriosus. We present a case of patent ductus arteriosus which caused obstruction of the left main bronchus.

Download Full-text

Rescue procedure for left main bronchus obstruction after patent ductus arteriosus clipping: a case report

Surgical Case Reports ◽

10.1186/s40792-018-0471-y ◽

2018 ◽

Vol 4 (1) ◽

Author(s):

Yukiko Ban ◽

Masakazu Abe

Keyword(s):

Case Report ◽

Patent Ductus Arteriosus ◽

Main Bronchus ◽

Ductus Arteriosus ◽

Left Main Bronchus ◽

Left Main ◽

Rescue Procedure ◽

Patent Ductus

Download Full-text

Left main bronchus obstruction after patent ductus arteriosus ligation: An unusual complication

International Journal of Pediatric Otorhinolaryngology ◽

10.1016/j.ijporl.2012.09.002 ◽

2012 ◽

Vol 76 (12) ◽

pp. 1855-1856 ◽

Cited By ~ 3

Author(s):

L.L. Harris ◽

R. Krishnamurthy ◽

L.P. Browne ◽

D.L.S. Morales ◽

E.M. Friedman

Keyword(s):

Patent Ductus Arteriosus ◽

Main Bronchus ◽

Ductus Arteriosus ◽

Left Main Bronchus ◽

Unusual Complication ◽

Left Main ◽

Patent Ductus

Download Full-text

Wheezing caused by a Patent ductus arteriosus occluder：Case Report and Review of the Literature

10.22541/au.162526928.81827291/v1 ◽

2021 ◽

Author(s):

Yong Wu ◽

Hanmin Liu ◽

Ling Gu ◽

Li Wang ◽

Ming Su

Keyword(s):

Patent Ductus Arteriosus ◽

Respiratory Infections ◽

Main Bronchus ◽

Ductus Arteriosus ◽

Left Main ◽

Recurrent Wheezing ◽

Occlusion Device ◽

Inner Diameter ◽

Infants And Young Children ◽

Patent Ductus

Wheezing is often occurred in infants and young children with respiratory infections. For children with recurrent wheezing, after controlling their wheezing, they should be alert to rare diseases. Here, We report a case of wheezing following the application of the patent ductus arteriosus occlusion device ADOII (AGA Medical Corporation, Golden Valley,MN) with the occlusion device pressing against the inner diameter of the adjacent left main bronchus. After the pressure end of the occluder was removed, the child’s wheezing was effectively relieved

Download Full-text

Ligation of left pulmonary artery instead of patent ductus arteriosus

Cardiology in the Young ◽

10.1017/s1047951120002784 ◽

2020 ◽

Vol 30 (12) ◽

pp. 1943-1945

Author(s):

Semih Murat Yucel ◽

Irfan Oguz Sahin

Keyword(s):

Surgical Treatment ◽

Pulmonary Artery ◽

Patent Ductus Arteriosus ◽

Surgical Complication ◽

Ductus Arteriosus ◽

Left Pulmonary Artery ◽

Artery Ligation ◽

Surgical Closure ◽

Post Operative Period ◽

Patent Ductus

AbstractDuctus arteriosus is an essential component of fetal circulation. Due to occurring changes in the cardiopulmonary system physiology after birth, ductus arteriosus closes. Patent ductus arteriosus can be closed by medical or invasive (percutaneous or surgical) treatment methods. Percutaneous or surgical closure of patent ductus arteriosus can be performed for the cases that medical closure failed. Surgical treatment is often preferred method for closure of patent ductus arteriosus in the neonatal period. The most common surgical complications are pneumothorax, recurrent laryngeal nerve injury, bleeding, and recanalisation. A very rare surgical complication is left pulmonary artery ligation that has been presented in a few cases in the literature. Echocardiography control should be performed in the early post-operative period, especially in patients with clinical suspicion. If reoperation is required, it should never be delayed. We report a newborn patient whose left pulmonary artery ligated accidentally during patent ductus arteriosus closure surgery and surgical correction of this complication at the early post-operative period.

Download Full-text

SURGICAL CLOSURE OF ATYPICAL PATENT DUCTUS ARTERIOSUS

Journal of Thoracic Surgery ◽

10.1016/s0096-5588(20)30930-2 ◽

1956 ◽

Vol 31 (3) ◽

pp. 332-337

Author(s):

N.A. Antonius ◽

L.G. Massarelli ◽

A.D. Crecca

Keyword(s):

Patent Ductus Arteriosus ◽

Ductus Arteriosus ◽

Surgical Closure ◽

Patent Ductus

Download Full-text

Low-Dose Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-Resistant or Contraindicated Preterm Infants: Three Cases Reports

American Journal of Perinatology Reports ◽

10.1055/s-0037-1615260 ◽

2017 ◽

Vol 07 (04) ◽

pp. e230-e233 ◽

Cited By ~ 1

Author(s):

Shun Matsumura ◽

Ayumi Oshima ◽

Sumie Fujinuma ◽

Kosuke Tanaka ◽

Nobuhiko Nagano ◽

...

Keyword(s):

Patent Ductus Arteriosus ◽

Premature Infants ◽

Ductus Arteriosus ◽

Limited Data ◽

Gastrointestinal Complications ◽

Surgical Closure ◽

Institutional Ethics ◽

Intravenous Paracetamol ◽

Administration Protocol ◽

Patent Ductus

Background Although indomethacin (IND) is the standard treatment for hemodynamically significant patent ductus arteriosus (hsPDA) in Japan, it may be associated with renal impairment and gastrointestinal complications. The use of paracetamol for hsPDA closure has recently increased. Unlike IND, paracetamol does not have a peripheral vasoconstrictive effect and can be given to infants with contraindications to IND. Based on limited data available from randomized trials, paracetamol and IND seem to have similar effects. However, there have been no reports of the use of paracetamol for hsPDA in Japan. Cases Our drug administration protocol was approved by the institutional ethics committee after purchasing a clinical trial insurance. In three premature infants in whom IND was contraindicated or ineffective, a 7.5 mg/kg of paracetamol was intravenously administered every 6 hour for 3 days after obtaining parental consents. A temporary hsPDA closure was observed in two of the three infants. However, all three infants eventually needed surgical closure. No side effects, such as hepatic and renal dysfunctions, and adverse events were reported. Conclusion The intravenous administration of paracetamol was safe and feasible in premature infants with hsPDA. Future clinical trials with optimized dose and timing of administration are needed.

Download Full-text